Silence Therapeutics (SLN) Other Operating Expenses (2024 - 2025)
Silence Therapeutics' (SLN) quarterly Other Operating Expenses came in at -$20.7 million in Q2 2025, down 11.03% year-on-year from -$23.3 million in Q2 2024, and up 27.06% quarter-over-quarter from -$28.4 million in Q1 2025.
Silence Therapeutics (SLN) Other Operating Expenses (2024 - 2025) Analysis & Trends
Silence Therapeutics has disclosed Other Operating Expenses across 2 years of filings, most recently posting -$20.7 million for Q2 2025.
- Other Operating Expenses for Q2 2025 came in at -$20.7 million, down 11.03% year-over-year; the trailing twelve-month figure through Mar 2026 was -$20.7 million (up 55.98% YoY), and the FY2024 annual result was -$88.6 million, up 5.97% from the prior year.
- Other Operating Expenses came in at -$20.7 million for Q2 2025 at Silence Therapeutics, up from -$28.4 million in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of -$16.5 million in Q1 2024 to a low of -$28.4 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Silence Therapeutics | 966.41 Mn | 896.33 Mn | 411,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -20.70 Mn |
| Mar 31, 2025 | -28.38 Mn |
| Jun 30, 2024 | -18.64 Mn |
| Mar 31, 2024 | -16.45 Mn |